RenovoRx, Inc. (RNXT)
NASDAQ · Manufacturing · Surgical & medical instruments & apparatus
RNXT price, last 12 months
Key stats
- Previous close
- $1.12
- Open
- $1.16
- Day range
- $1.02 – $1.16
- 52-week range
- $0.7550 – $2.59
- Volume
- 421.1K
- Avg volume (20 days)
- 495.5K
- Market cap
- $50.2M
Performance
Technicals and fundamentals
About RenovoRx, Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NASDAQ
- Market cap
- $50.2M